Cargando…
VARC consensus report: the FDA perspective(†)
Autores principales: | Hillebrenner, Matthew G., Swain, Julie A., Zuckerman, Bram |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021389/ https://www.ncbi.nlm.nih.gov/pubmed/21216740 http://dx.doi.org/10.1093/eurheartj/ehq414 |
Ejemplares similares
-
Consensus-based Standards and Indicators to strengthen trauma center injury and violence prevention programs
por: Adams, Christy, et al.
Publicado: (2021) -
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
por: Borén, Jan, et al.
Publicado: (2020) -
Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020
por: Martinez-Cabriales, Sylvia A., et al.
Publicado: (2021) -
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
por: Ference, Brian A., et al.
Publicado: (2017) -
Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement
por: Corrado, Domenico, et al.
Publicado: (2015)